These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 4152974)

  • 21. Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
    Biochem Pharmacol; 1996 Jul; 52(1):29-34. PubMed ID: 8678905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is drug inhibition of dopamine uptake a misinterpretation of in vitro experiments?
    Bauman PA; Maitre L
    Nature; 1976 Dec 23-30; 264(5588):789-90. PubMed ID: 1012321
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of psychotropic drugs on the distribution of 3H-dopamine into compartments of rat striatal synaptosomes and on subsequent depolarization-induced 3H-dopamine release.
    de Langen CD; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Mar; 311(2):169-77. PubMed ID: 7383166
    [No Abstract]   [Full Text] [Related]  

  • 24. Uptake of (3H)-catecholamines by homogenates of rat corpus striatum and cerebral cortex: effects of amphetamine analogues.
    Harris JE; Baldessarini RJ
    Neuropharmacology; 1973 Jul; 12(7):669-79. PubMed ID: 4730376
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine.
    Liang NY; Rutledge CO
    Biochem Pharmacol; 1982 Mar; 31(6):983-92. PubMed ID: 7082379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes.
    Dubocovich ML; Zahniser NR
    Biochem Pharmacol; 1985 Apr; 34(8):1137-44. PubMed ID: 3158318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An evaluation of various antiparkinsonian agents as releasing agents and uptake inhibitors for 3H-dopamine in slices of rat neostriatum.
    Orlansky H; Heikkila RE
    Eur J Pharmacol; 1974 Dec; 29(2):284-91. PubMed ID: 4442446
    [No Abstract]   [Full Text] [Related]  

  • 28. Rapid determination of dopamine uptake in synaptosomal preparations.
    Cooper DO; Carlson KR
    J Neurosci Methods; 1983 Oct; 9(2):157-62. PubMed ID: 6645605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence that amphetamine and Na+ gradient reversal increase striatal synaptosomal dopamine synthesis through carrier-mediated efflux of dopamine.
    Connor CE; Kuczenski R
    Biochem Pharmacol; 1986 Sep; 35(18):3123-30. PubMed ID: 3092833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency-dependent effects of neuronal uptake inhibitors on the autoreceptor-mediated modulation of dopamine and acetylcholine release from the rabbit striatum.
    Cubeddu LX; Hoffmann IS; James MK
    J Pharmacol Exp Ther; 1983 Jul; 226(1):88-94. PubMed ID: 6408246
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of benapyrzine, a new antiparkinson drug, on dopamine uptake into corpus striatum.
    Palfreyman MG; Palfreyman ES; Clark MS
    Eur J Pharmacol; 1974 Oct; 28(2):379-83. PubMed ID: 4418659
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibitory effect of xylamine on the uptake of [3H]dopamine into isolated striatal synaptosomes of the rats.
    Liang P; Chang SS; Cheng JT
    Neurosci Lett; 1993 Apr; 153(2):181-4. PubMed ID: 8392155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent investigations on the mechanism of action of nomifensine.
    Schacht U; Leven M; Gerhards HJ; Hunt P; Raynaud JP
    Int Pharmacopsychiatry; 1982; 17 Suppl 1():21-34. PubMed ID: 6182120
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of piroheptine, a new antiparkinson drug, on dopamine uptake into synaptosomes from corpus striatum of rat brain.
    Ohashi T; Akita H; Tamura T; Noda K; Honda F
    Arzneimittelforschung; 1972 Jun; 22(6):966-72. PubMed ID: 5068358
    [No Abstract]   [Full Text] [Related]  

  • 36. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine.
    Horn AS; Snyder SH
    J Pharmacol Exp Ther; 1972 Mar; 180(3):523-30. PubMed ID: 5012779
    [No Abstract]   [Full Text] [Related]  

  • 37. The conformation of dopamine at its uptake site; further studies with rigid analogues.
    Horn AS
    J Pharm Pharmacol; 1974 Sep; 26(9):735-7. PubMed ID: 4155754
    [No Abstract]   [Full Text] [Related]  

  • 38. Kinetics of dopamine and noradrenaline transport in synaptosomes from cerebellum, striatum and frontal cortex of normal and reeler mice.
    Efthimiopoulos S; Giompres P; Valcana T
    J Neurosci Res; 1991 Aug; 29(4):510-9. PubMed ID: 1838778
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of 3H-dopamine accumulation in reserpinized and normal rat striatum.
    Ross SB; Kelder D
    Acta Pharmacol Toxicol (Copenh); 1979 May; 44(5):329-35. PubMed ID: 474143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of nomifensine on acetylcholine and choline in the rat striatum and brainstem.
    Garattini S; Consolo S; Chittò G; Peri G; Ladinsky H
    Eur J Pharmacol; 1976 Jan; 35(1):199-201. PubMed ID: 1253820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.